Quantcast

Posts related to ‘drug patents’

Vermillion Scores Patent on Cancer Test (VRML)

Posted: March 28, 2012 at 10:10 am

Shares of diagnostics company Vermillion Inc. (NASDAQ: VRML) have jumped more than 20% this morning following the company’s announcement of a patent approval for another of its biomarkers used to ...
Read Full Story »

Teva Launches Generic Seroquel on First Day of Patent Loss (TEVA, AZN)

Posted: March 26, 2012 at 2:29 pm

We noted earlier today that AstraZeneca plc (NYSE: AZN) had lost a patent ruling and that the company’s anti-pyschotic drug Seroquel lost its patent protection today. That’s all it took ...
Read Full Story »

Pharma Value Beyond The Patent Expiration Cliff (PFE, MRK, BMY, TEVA, AMGN, GSK)

Posted: January 11, 2012 at 1:37 pm

The tide of patent expirations that is washing over big pharmaceutical houses is cresting now and investors have begun looking forward to how these companies will deal with some sharp ...
Read Full Story »

Lipitor OTC: What Next? (PFE, MRK, AZN, SNY, BMY, LLY, JNJ, AMGN)

Posted: August 4, 2011 at 9:26 am

Once patent protection expires on a prescription drug, the drug's maker can take a serious beating in revenue and profitability. One way to make up for the loss is to ...
Read Full Story »